CLINICAL_TRIALS
trial_result
· 2012-04-30
Clinical Trial Update: 18-Week, Randomized, Double-blind, Placebo Controlled, Forced Titration Study of Patients With Type 2 Diabetes [Phase 2]
Summary
A Phase 2 randomized, double-blind, placebo-controlled trial in Type 2 diabetes mellitus completed after an 18-week treatment period.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mannkind Corporation | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED